BE788516A
(fr)
|
1971-09-10 |
1973-03-07 |
Lonza Ag |
Procede de fabrication d'esters alcoxyacetylacetiques
|
GB1528382A
(en)
|
1974-12-26 |
1978-10-11 |
Teijin Ltd |
Cyclopentene diols and acyl esters thereof and processes for their preparation
|
DE2658401A1
(de)
|
1976-12-23 |
1978-07-06 |
Merck Patent Gmbh |
Cyclopentan-1-amine, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
|
US4575694A
(en)
|
1984-03-05 |
1986-03-11 |
Allied Corporation |
Coaxial connector
|
DE3900736A1
(de)
|
1989-01-12 |
1990-07-26 |
Hoechst Ag |
Positiv arbeitendes strahlungsempfindliches gemisch enthaltend einen mehrfunktionellen (alpha)-diazo-(beta)-ketoester, verfahren zu dessen herstellung und strahlungsempfindliches aufzeichnungsmaterial enthaltend dieses gemisch
|
US6642245B1
(en)
|
1990-02-01 |
2003-11-04 |
Emory University |
Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
|
US5204466A
(en)
|
1990-02-01 |
1993-04-20 |
Emory University |
Method and compositions for the synthesis of bch-189 and related compounds
|
US6703396B1
(en)
|
1990-02-01 |
2004-03-09 |
Emory University |
Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers
|
DE4014649A1
(de)
|
1990-05-08 |
1991-11-14 |
Hoechst Ag |
Neue mehrfunktionelle verbindungen mit (alpha)-diazo-ss-ketoester- und sulfonsaeureester-einheiten, verfahren zu ihrer herstellung und deren verwendung
|
GB9301000D0
(en)
|
1993-01-20 |
1993-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
US5922695A
(en)
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
SE9702772D0
(sv)
|
1997-07-22 |
1997-07-22 |
Astra Pharma Prod |
Novel compounds
|
US5935946A
(en)
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
WO1999025345A1
(en)
|
1997-11-14 |
1999-05-27 |
Merck & Co., Inc. |
Alpha-1a adrenergic receptor antagonists
|
CN1325385A
(zh)
|
1998-11-09 |
2001-12-05 |
詹姆斯·布莱克基金有限公司 |
胃泌素和缩胆囊素受体配体
|
GB2345058A
(en)
|
1998-12-01 |
2000-06-28 |
Cerebrus Pharm Ltd |
Hydroxypyridone compounds useful in the treatment of oxidative damage to the central nervous system
|
BR9916583A
(pt)
|
1998-12-25 |
2001-09-25 |
Shionogi & Co |
Derivados heteroaromáticos tendo uma atividade inibitória contra integrase de hiv
|
EP1297834A4
(en)
|
2000-06-14 |
2007-05-09 |
Shionogi & Co |
ENZYME INHIBITOR HAVING TWO DIVALENT METAL IONS AS ACTIVE CENTERS
|
MXPA04000646A
(es)
|
2001-08-10 |
2004-03-18 |
Shionogi & Co |
Agente antiviral.
|
PL370355A1
(en)
|
2001-10-03 |
2005-05-16 |
Ucb, S.A. |
Pyrrolidinone derivatives
|
EA007060B1
(ru)
|
2001-10-26 |
2006-06-30 |
Иституто Ди Ричерке Ди Биолоджиа Молеколаре П. Анджелетти Спа |
N-замещённые гидроксипиримидинон-карбоксамидные ингибиторы вич интегразы
|
WO2003042176A1
(fr)
|
2001-11-13 |
2003-05-22 |
Shiseido Co., Ltd. |
Compose azabicyclo, inhibiteur de metalloprotease matricielle et preparation cutanee
|
WO2004004657A2
(en)
|
2002-07-09 |
2004-01-15 |
Bristol-Myers Squibb Company |
Hiv integrase inhibitors
|
US7517532B2
(en)
|
2002-09-11 |
2009-04-14 |
Merck & Co., Inc. |
Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors
|
BRPI0306214B1
(pt)
|
2002-11-20 |
2017-08-08 |
Japan Tobacco Inc. |
4-oxoquinoline compound and use of this as a hiv integrase inhibitor
|
PT1583542E
(pt)
|
2003-01-14 |
2008-09-17 |
Gilead Sciences Inc |
Composições e métodos para terapia de combinação antiviral
|
TW200510425A
(en)
|
2003-08-13 |
2005-03-16 |
Japan Tobacco Inc |
Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
|
TW200528440A
(en)
|
2003-10-31 |
2005-09-01 |
Fujisawa Pharmaceutical Co |
2-cyanopyrrolidinecarboxamide compound
|
CA2554120A1
(en)
|
2004-01-30 |
2005-08-18 |
Merck & Co., Inc. |
N-benzyl-3,4-dihydroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as hiv integras inhibitors
|
JP2007528396A
(ja)
|
2004-03-09 |
2007-10-11 |
メルク エンド カムパニー インコーポレーテッド |
Hivインテグラーゼ阻害薬
|
WO2006028523A2
(en)
|
2004-04-29 |
2006-03-16 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO USDC Technology Transfer Office |
Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors
|
WO2005110399A2
(en)
|
2004-04-29 |
2005-11-24 |
The Regents Of The University Of California |
Zinc-binding groups for metalloprotein inhibitors
|
EP1756114B1
(en)
|
2004-05-07 |
2014-11-19 |
Merck Sharp & Dohme Corp. |
Hiv integrase inhibitors
|
US7273859B2
(en)
|
2004-05-12 |
2007-09-25 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors: cyclic pyrimidinone compounds
|
MY134672A
(en)
|
2004-05-20 |
2007-12-31 |
Japan Tobacco Inc |
Stable crystal of 4-oxoquinoline compound
|
WO2005113509A1
(en)
|
2004-05-20 |
2005-12-01 |
Japan Tobacco Inc. |
Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
|
EP3287130A1
(en)
|
2004-05-21 |
2018-02-28 |
Japan Tobacco Inc. |
Combinations comprising a 4-isoquinolone derivative and protease inhibitors
|
US7550463B2
(en)
|
2004-09-15 |
2009-06-23 |
Shionogi & Co., Ltd. |
Carbamoylpyridone derivatives having inhibitory activity against HIV integrase
|
EP1973906A1
(en)
|
2004-12-23 |
2008-10-01 |
Virochem Pharma Inc. |
Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase
|
US7858788B2
(en)
|
2005-02-21 |
2010-12-28 |
Shionogi & Co., Ltd. |
Bicyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
|
HUE044978T2
(hu)
|
2005-04-28 |
2019-11-28 |
Viiv Healthcare Co |
HIV integráz gátló aktivitású policiklusos karbamoilpiridon származék
|
WO2006125048A2
(en)
|
2005-05-16 |
2006-11-23 |
Gilead Sciences, Inc. |
Hiv-integrase inhibitor compounds
|
CA2616314A1
(en)
|
2005-07-27 |
2007-02-01 |
Gilead Sciences, Inc. |
Antiviral phosphonate conjugates for inhibition of hiv
|
EA200801144A1
(ru)
|
2005-10-27 |
2008-10-30 |
Сионоги Энд Ко., Лтд. |
Полициклическое карбамоилпиридоновое производное, обладающее ингибиторной активностью в отношении интегразы вич
|
EP1976517A1
(en)
|
2005-12-30 |
2008-10-08 |
Gilead Sciences, Inc. |
Methods for improving the pharmacokinetics of hiv integrase inhibitors
|
US7601844B2
(en)
|
2006-01-27 |
2009-10-13 |
Bristol-Myers Squibb Company |
Piperidinyl derivatives as modulators of chemokine receptor activity
|
EP1978960A4
(en)
|
2006-02-01 |
2009-12-02 |
Japan Tobacco Inc |
USE OF 6- (3-CHLORO-2-FLUORBENZYL) -1 - [(2S) -1-HYDROXY-3-METHYLBUTAN-2-YL [-7-METHOXY-4-OXO-1,4-DIHYDROCHINOLINE-3- CARBOXYLIC ACID OR SALT THEREOF FOR THE TREATMENT OF RETROVIRUS INFECTION
|
WO2007102499A1
(ja)
|
2006-03-06 |
2007-09-13 |
Japan Tobacco Inc. |
4-オキソキノリン化合物の製造方法
|
US8383819B2
(en)
|
2006-03-06 |
2013-02-26 |
Japan Tobacco Inc. |
Method for producing 4-oxoquinoline compound
|
US7893055B2
(en)
|
2006-06-28 |
2011-02-22 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
MX2009000661A
(es)
|
2006-07-19 |
2009-03-27 |
Univ Georgia Res Found |
Piridinon-diceto-acidos: inhibidores de replicacion de vih en terapia de combinacion.
|
EP2057165B1
(en)
|
2006-09-07 |
2011-03-16 |
Industrial Research Limited |
Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
|
JP5221544B2
(ja)
|
2006-09-12 |
2013-06-26 |
ギリアード サイエンシーズ, インコーポレイテッド |
インテグラーゼ阻害剤を調製するためのプロセスおよび中間体
|
JP2010506913A
(ja)
|
2006-10-18 |
2010-03-04 |
メルク エンド カムパニー インコーポレーテッド |
Hivインテグラーゼ阻害剤
|
ES2602784T3
(es)
|
2007-02-23 |
2017-02-22 |
Gilead Sciences, Inc. |
Moduladores de las propiedades farmacocinéticas de los agentes terapéuticos
|
US20080280945A1
(en)
|
2007-05-09 |
2008-11-13 |
Sachin Lohani |
Crystalline forms of an HIV integrase inhibitor
|
CA2691736A1
(en)
|
2007-06-29 |
2009-01-08 |
Gilead Sciences, Inc. |
Combination of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and lopinavir for the treatment of a viral infection in a human
|
CN101686972B
(zh)
|
2007-06-29 |
2013-08-14 |
吉里德科学公司 |
治疗用组合物和方法
|
US20090258939A1
(en)
|
2007-07-31 |
2009-10-15 |
Wendye Robbins |
Pyrone analog compositions and methods
|
AR068403A1
(es)
|
2007-09-11 |
2009-11-18 |
Gilead Sciences Inc |
Proceso e intermediarios para la preparacion de inhibidores de integrasa
|
EP2757096A1
(en)
|
2007-11-16 |
2014-07-23 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
GB0803019D0
(en)
|
2008-02-19 |
2008-03-26 |
Btg Int Ltd |
Fluorinated compounds
|
US8129398B2
(en)
|
2008-03-19 |
2012-03-06 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
US20100272811A1
(en)
|
2008-07-23 |
2010-10-28 |
Alkermes,Inc. |
Complex of trospium and pharmaceutical compositions thereof
|
WO2010011815A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
ES2607403T3
(es)
|
2008-07-25 |
2017-03-31 |
Shionogi & Co., Ltd. |
Compuestos químicos como intermedios sintéticos
|
WO2010011818A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
SI2320908T1
(sl)
|
2008-07-25 |
2014-05-30 |
Viiv Healthcare Company |
Predzdravila dolutegravirja
|
WO2010011819A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Chemical compounds
|
EP2330902B1
(en)
|
2008-07-25 |
2012-11-14 |
GlaxoSmithKline LLC |
Chemical compounds
|
US8624023B2
(en)
|
2008-12-11 |
2014-01-07 |
Shionogi & Co., Ltd. |
Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates
|
KR101682058B1
(ko)
|
2008-12-11 |
2016-12-02 |
비이브 헬쓰케어 컴퍼니 |
카르바모일피리돈 hiv 인테그라제 억제제를 위한 제조방법 및 중간체
|
US8835461B2
(en)
|
2009-03-26 |
2014-09-16 |
Shionogi & Co., Ltd. |
Substituted 3-hydroxy-4-pyridone derivative
|
TWI518084B
(zh)
|
2009-03-26 |
2016-01-21 |
鹽野義製藥股份有限公司 |
哌喃酮與吡啶酮衍生物之製造方法
|
US8338441B2
(en)
|
2009-05-15 |
2012-12-25 |
Gilead Sciences, Inc. |
Inhibitors of human immunodeficiency virus replication
|
ES2671550T3
(es)
|
2009-06-15 |
2018-06-07 |
Shionogi & Co., Ltd. |
Derivado de carbamoilpiridona policíclica sustituida
|
US8637674B2
(en)
|
2009-09-02 |
2014-01-28 |
Ewha University-Industry Collaboration Foundation |
Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same
|
HUE026849T2
(en)
|
2010-01-27 |
2016-08-29 |
Viiv Healthcare Company Corp Service Company |
Therapeutic combination containing dolutegravir, abacavir and lamivudine
|
MX2012009869A
(es)
|
2010-02-26 |
2012-09-12 |
Japan Tobacco Inc |
Derivado de 1, 3,4, 8-tetrahidro-2h-pirido[1, 2-a]pirazina y sus uso como inhibidor de la integrasa del vih.
|
TWI582097B
(zh)
|
2010-03-23 |
2017-05-11 |
Viiv醫療保健公司 |
製備胺甲醯吡啶酮衍生物及中間體之方法
|
WO2011139637A1
(en)
|
2010-05-03 |
2011-11-10 |
Philadelphia Health & Education Corporation |
Small-molecule modulators of hiv-1 capsid stability and methods thereof
|
US9102614B2
(en)
|
2010-07-02 |
2015-08-11 |
Gilead Sciences, Inc. |
Naphth-2-ylacetic acid derivatives to treat AIDS
|
SG186821A1
(en)
|
2010-07-02 |
2013-02-28 |
Gilead Sciences Inc |
2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
|
EP2595986A2
(en)
|
2010-07-14 |
2013-05-29 |
Addex Pharma SA |
Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors
|
SI3456721T1
(sl)
|
2010-08-05 |
2021-05-31 |
Shionogi & Co., Ltd |
Postopek izdelave spojin, ki imajo HIV integraza-inhibitorno aktivnost
|
MX2013003139A
(es)
|
2010-09-24 |
2013-06-18 |
Shionogi & Co |
Profarmaco de derivado de carbamoilpiridona policiclica substituida.
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
PT2699558T
(pt)
|
2011-04-21 |
2016-12-29 |
Gilead Sciences Inc |
Compostos de benzotiazole e a sua utilização farmacêutica
|
WO2012151361A1
(en)
|
2011-05-03 |
2012-11-08 |
Concert Pharmaceuticals Inc. |
Carbamoylpyridone derivatives
|
WO2012151567A1
(en)
|
2011-05-05 |
2012-11-08 |
St. Jude Children's Research Hospital |
Pyrimidinone compounds and methods for preventing and treating influenza
|
WO2013006738A1
(en)
|
2011-07-06 |
2013-01-10 |
Gilead Sciences, Inc. |
Compounds for the treatment of hiv
|
CN102863512B
(zh)
|
2011-07-07 |
2016-04-20 |
上海泓博智源医药技术有限公司 |
抗病毒化合物
|
ES2613180T3
(es)
|
2011-09-14 |
2017-05-23 |
Mapi Pharma Limited |
Forma amorfa de la sal sódica dolutegravir
|
US9200009B2
(en)
|
2011-10-12 |
2015-12-01 |
Shionogi & Co., Ltd. |
Polycyclic pyridone derivative having integrase inhibitory activity
|
CN104114559B
(zh)
|
2011-12-12 |
2016-08-24 |
拜耳知识产权有限责任公司 |
氨基取代的咪唑并哒嗪
|
NZ622769A
(en)
|
2012-04-20 |
2017-06-30 |
Gilead Sciences Inc |
Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection
|
WO2014008636A1
(en)
|
2012-07-11 |
2014-01-16 |
Merck Sharp & Dohme Corp. |
Macrocyclic compounds as hiv integrase inhibitors
|
WO2014014933A1
(en)
|
2012-07-20 |
2014-01-23 |
Merck Sharp & Dohme Corp. |
Hiv treatment with amido-substituted pyrimidinone derivatives
|
WO2014018449A1
(en)
|
2012-07-25 |
2014-01-30 |
Merck Sharp & Dohme Corp. |
Substituted naphthyridinedione derivatives as hiv integrase inhibitors
|
PT2880017T
(pt)
|
2012-08-03 |
2016-12-14 |
Gilead Sciences Inc |
Processo e intermediários para preparar inibidores da integrase
|
JP6204484B2
(ja)
|
2012-11-08 |
2017-09-27 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
キナーゼモジュレーターとして有用なヘテロアリール置換ピリジル化合物
|
CN104902905A
(zh)
|
2012-12-14 |
2015-09-09 |
葛兰素史克有限责任公司 |
药物组合物
|
WO2014099586A1
(en)
*
|
2012-12-17 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
4-pyridinonetriazine derivatives as hiv integrase inhibitors
|
US20140221355A1
(en)
|
2012-12-21 |
2014-08-07 |
Gilead Sciences, Inc. |
Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
|
PT3608325T
(pt)
*
|
2012-12-21 |
2022-10-17 |
Gilead Sciences Inc |
Compostos carbamoílpiridona policíclicos e sua utilização farmacêutica
|
EP2934482A4
(en)
|
2012-12-21 |
2016-07-20 |
Merck Sharp & Dohme |
ADMINISTRATIVE FORMULATIONS
|
TW201431859A
(zh)
|
2012-12-27 |
2014-08-16 |
Japan Tobacco Inc |
經取代之螺吡啶並[1,2-a]吡□衍生物及該衍生物作爲HIV整合酶抑制劑之醫藥用途
|
WO2014200880A1
(en)
|
2013-06-13 |
2014-12-18 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
|
ES2645192T3
(es)
*
|
2013-07-12 |
2017-12-04 |
Gilead Sciences, Inc. |
Compuestos de carbamoilpiridona policíclica y su uso para el tratamiento de infecciones por VIH
|
NO2865735T3
(lv)
*
|
2013-07-12 |
2018-07-21 |
|
|
WO2015039348A1
(en)
*
|
2013-09-23 |
2015-03-26 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
|
KR102102516B1
(ko)
|
2013-09-27 |
2020-04-20 |
머크 샤프 앤드 돔 코포레이션 |
Hiv 인테그라제 억제제로서 유용한 치환된 퀴놀리진 유도체
|
US20150146340A1
(en)
|
2013-11-26 |
2015-05-28 |
Qualcomm Incorporated |
Multilayer ceramic capacitor including at least one slot
|
WO2015089847A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Spirocyclic heterocycle compounds useful as hiv integrase inhibitors
|
EP3096763B1
(en)
|
2014-01-21 |
2019-12-25 |
Laurus Labs Limited |
Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
|